Targeting Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia

The selective persistence of rare leukemic stem cells following therapy-induced remission implies unique resistance mechanisms of leukemic stem cells towards conventional therapeutic strategies and that leukemic stem cells represent the cellular origin of relapse.